 Braxia Scientific Corp CSE:BRAX OTCMKTS:BRAXF FRA:496 announced the launch of its psilocybin-assisted clinical therapy training program for medical professionals. Braxia said it hopes to develop a new generation of independent physicians, psychologists and psychotherapists that are interested in using psilocybin to treat depression. 